Terranueva Corporation (CNSX: TEQ)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
Terranueva Corporation (CNSX: TEQ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.02M.
trading between 0.01 and 0.05.
Tweenvest scores Terranueva Corporation across four factors: quality 8/100. Its strongest factor is quality.
TEQ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.02M
- Revenue (TTM)
- $660.12K
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 2.23
- 52-week high
- CA$0.05
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 45.97M
- Employees
- —
- Next earnings
- —
About Terranueva Corporation
Terranueva Corporation aims to cultivate cannabis for both therapeutic and recreational consumption. The firm was founded in 2017 and conducts its operations from its principal office situated in Laval, Canada.
- ISIN
- CA88105H1010
- Founded
- 2017
- Listed since
- Jan 23, 2008
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.